James M. Frates
Chief Financial Officer
Chief Financial Officer at Amylyx Pharmaceuticals, Inc., filing insider transactions on 2026-03-02.
Total Purchases
—
0 transactions
Total Sales
$115K
1 transaction
Companies Traded
1
1 total filings
Active Since
2026-03-02
Last: 2026-03-02
Other Reporting Insiders at Amylyx Pharmaceuticals, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-03-02 | AMLX | Sale | 7,909 | $14.52 | $115K | 165.6K | SEC ↗ |
Director & Co-Chief Executive Officer